Suppr超能文献

聚糖配对聚焦:单克隆抗体不对称Fc N-聚糖配对对Fc受体相互作用的产生及影响

Spotlight on Glycan Pairing: The Generation and Impact of Monoclonal Antibody Asymmetrical Fc N‑Glycan Pairs on Fc Receptor Interaction.

作者信息

Meudt Maximilian, Baumeister Julia, Machal Erik M F, Knape Matthias J, Mizaikoff Boris, Ebert Sybille, Rosenau Frank, Blech Michaela, Higel Fabian

机构信息

Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss 88400, Germany.

Institute of Analytical and Bioanalytical Chemistry, Ulm University, Ulm 89069, Germany.

出版信息

ACS Pharmacol Transl Sci. 2025 May 21;8(6):1756-1767. doi: 10.1021/acsptsci.5c00185. eCollection 2025 Jun 13.

Abstract

Monoclonal antibodies' Fc N-glycans play a crucial role in their therapeutic efficacy, as they influence effector functions through Fc receptor binding. However, the impact of asymmetrical Fc glyco-pairs is often overlooked in assessing Fc receptor binding and effector functions. This study addresses this gap by generating pure asymmetrical Fc glyco-pairs and evaluating their Fc receptor binding properties, thereby providing a comprehensive understanding of the impact of Fc N-glycans. Utilizing redox pairing and affinity chromatography, homogeneously asymmetrical Fc glyco-pairs were generated, and their interaction properties toward Fcγ receptors IIIa, IIa, IIb, and I were determined by surface plasmon resonance. The results underscore the importance of considering the apparent glycan distribution of Fc N-glycans as glycan pairing was found to individually influence Fc receptor binding. Notably, single afucosylation significantly increased the affinity for FcγRIIIa, while the effect of galactosylation was detectable but less pronounced. Galactosylation, however, played a crucial role in FcγRIIa binding, with asymmetrical galactosylation being sufficient for the whole effect. In contrast, for FcγRIIb, afucosylation was more important, while galactosylation played a minor role. Furthermore, glycosylation-dependent Fc-FcγRI complex stability differences could be resolved, challenging the commonly held belief that this interaction is glycosylation independent.

摘要

单克隆抗体的Fc N-聚糖在其治疗效果中起着关键作用,因为它们通过Fc受体结合影响效应功能。然而,在评估Fc受体结合和效应功能时,不对称Fc糖对的影响常常被忽视。本研究通过生成纯的不对称Fc糖对并评估其Fc受体结合特性来填补这一空白,从而全面了解Fc N-聚糖的影响。利用氧化还原配对和亲和色谱法,生成了均匀的不对称Fc糖对,并通过表面等离子体共振测定了它们与Fcγ受体IIIa、IIa、IIb和I的相互作用特性。结果强调了考虑Fc N-聚糖的表观聚糖分布的重要性,因为发现聚糖配对会单独影响Fc受体结合。值得注意的是,单去岩藻糖基化显著增加了对FcγRIIIa的亲和力,而半乳糖基化的影响虽然可检测到但不太明显。然而,半乳糖基化在FcγRIIa结合中起关键作用,不对称半乳糖基化足以产生整体效应。相比之下,对于FcγRIIb,去岩藻糖基化更重要,而半乳糖基化起次要作用。此外,糖基化依赖性的Fc-FcγRI复合物稳定性差异可以得到解决,这挑战了普遍认为这种相互作用与糖基化无关的观点。

相似文献

3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

本文引用的文献

6
Antibodies to watch in 2024.2024 年值得关注的抗体药物
MAbs. 2024 Jan-Dec;16(1):2297450. doi: 10.1080/19420862.2023.2297450. Epub 2024 Jan 5.
8
Therapeutic Antibodies in Medicine.医学中的治疗性抗体。
Molecules. 2023 Sep 5;28(18):6438. doi: 10.3390/molecules28186438.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验